Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Pharma channel feed
Trade group tells FDA that semaglutide is not too 'complex' for compounding
5 months ago
FDA+
Bluebird and Vertex's sickle cell gene therapies to kick off new Medicaid access model
5 months ago
FDA+
GSK partners with Rgenta on RNA-targeted small molecules for oncology, other areas
5 months ago
Startups
Deals
Ro’s weight loss business more than doubled in the last year. Now it’s trying to prove its program works
5 months ago
Startups
Health Tech
Dewpoint partners its ALS program, eyes JPM to raise a Series D
5 months ago
Startups
Deals
Lilly beats Novo in bellwether head-to-head weight loss study
5 months ago
R&D
GSK makes another ADC deal, this time with BioNTech's partner DualityBio
5 months ago
Deals
China
Lilly drops body mass ranges from FDA label for weight loss drug
5 months ago
FDA+
GSK terminates Phase 2 trial of HBV therapeutic vaccine
5 months ago
R&D
SEC and Kiromic settle over biotech's failure to disclose clinical trial holds ahead of stock offering
5 months ago
Law
Eli Lilly, Pfizer stress independence of telehealth partners in response to senators
5 months ago
FDA+
Coherus makes final, $483M pivot away from biosimilars
5 months ago
Deals
Takeda to pay $200M for rights to anemia drug from Keros
5 months ago
Deals
Gilead makes another ADC move, inking up to $415M pact with Tubulis
5 months ago
Startups
Deals
Roche teams up with Chicago autoimmune biotech COUR Pharmaceuticals
5 months ago
Deals
J&J looks to expand Tremfya in two pediatric indications
5 months ago
FDA+
Biocon lands FDA approval for another Stelara biosimilar
5 months ago
FDA+
Novartis pays $1B upfront for PTC's Phase 2 Huntington's drug
5 months ago
Deals
FDA is looking into hematology risks after patients take bluebird's Skysona gene therapy
5 months ago
Cell/Gene Tx
FDA+
Novartis to cut 139 jobs in NJ as part of commercial refocus
5 months ago
People
Advanz Pharma faces revocation of European authorization for liver disease drug Ocaliva
5 months ago
Bristol Myers sues the federal government over 340B, following other drugmakers
5 months ago
Law
The Biden administration wants Medicare and Medicaid to cover GLP-1s. Will the Trump White House allow it?
5 months ago
FDA+
Soleno’s rare pediatric disease drug faces PDUFA delay by three months
5 months ago
FDA+
First page
Previous page
20
21
22
23
24
25
26
Next page
Last page